Franklin, Parlapiano, Turner & Welch’s Allergan plc AGN Stock Holding History

Franklin, Parlapiano, Turner & Welch’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-113	Closed	-$27K	–	124
2017 Q1	$27K	Hold	113	–	–	0.01%	93
2016 Q4	$24K	Hold	113	–	–	0.01%	92
2016 Q3	$26K	Hold	113	–	–	0.01%	88
2016 Q2	$26K	Hold	113	–	–	0.01%	84
2016 Q1	$30K	Hold	113	–	–	0.02%	81
2015 Q4	$35K	Buy	+113	New	+$33.6K	0.02%	75

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch's AGN Position: Q2 2017 in Review

Franklin, Parlapiano, Turner & Welch sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 113 shares — an estimated $27K sold.

Franklin, Parlapiano, Turner & Welch first reported a position in AGN in Q4 2015 and held it in 6 quarters. The position peaked at $35K in Q4 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

Franklin, Parlapiano, Turner & Welch reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
Franklin, Parlapiano, Turner & Welch sold 113 Allergan plc shares in Q2 2017, an estimated $27K.
Franklin, Parlapiano, Turner & Welch first reported a position in Allergan plc in Q4 2015 and held it in 6 quarters.
Franklin, Parlapiano, Turner & Welch's Allergan plc position peaked at $35K in Q4 2015.
1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2017, filed 17 Jul 2017.